Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Molecular Medicine (Cambridge, Mass.)|November 7, 2024
Single cell RNA-seq reveals cellular and transcriptional heterogeneity in the splenic CD11b<sup>+</sup>Ly6C<sup>high</sup> monocyte population expanded in sepsis-surviving miceHaruki Watanabe, Minakshi Rana, Myoungsun Son, et al.The Journal of Urology|September 8, 2005
Effects of pneumoperitoneal gases and pressures on transitional cell carcinoma adhesion, growth, apoptosis and necrosis: an in vitro studyBeng Jit Tan, Jun Sy Dy, Pui Yan Chiu, et al.Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.Frontiers in Immunology|September 22, 2018
Constitutive Vagus Nerve Activation Modulates Immune Suppression in Sepsis SurvivorsMinakshi Rana, Yurong Fei-Bloom, Myoungsun Son, et al.JCI Insight|May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific mannersByeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.Blood Cancer Journal|February 2, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitorsDeepti Gadi, Stephen P Martindale, Pui Yan Chiu, et al.Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.Leukemia|May 3, 2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLLGerardo Ferrer, Byeongho Jung, Pui Yan Chiu, et al.Nature Communications|November 28, 2022
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidatesAhmad Altiti, Mingzhu He, Sonya VanPatten, et al.Pageof 1